|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tenth Pre-Paid Advance |
Initial July Prepaid Advance |
First Supplemental Advance |
|
|
|
|
|
Stock price |
|
$ |
0.98 |
|
$ |
0.98 |
|
$ |
0.98 |
|
Risk free interest rate |
|
4.8 |
% |
4.6 |
% |
4.5 |
% |
Interest rate |
|
5.0 |
% |
5.0 |
% |
5.0 |
% |
Expected volatility |
|
106.2 |
% |
115.7 |
% |
111.6 |
% |
Expected dividend yield |
|
— |
% |
— |
% |
— |
% |
Remaining term (in years) |
|
0.2 |
0.3 |
0.4 |
The following table summarizes the Company’s stock-based compensation expense by line item for the three and nine months ended September 30, 2024 and 2023 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
September 30,
|
|
Nine months ended September 30, |
|
2024 |
|
2023 |
|
2024 |
|
2023 |
Research and development |
$ |
(1,341) |
|
|
$ |
626 |
|
|
$ |
(1,390) |
|
|
$ |
4,970 |
|
Selling, general and administrative |
2,987 |
|
|
6,282 |
|
|
15,120 |
|
|
18,481 |
|
Total |
$ |
1,647 |
|
|
$ |
6,908 |
|
|
$ |
13,730 |
|
|
$ |
23,451 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
10.0 |
Risk free interest rate |
3.0 |
% |
Expected volatility |
91.3 |
% |
Dividend yield |
— |
% |
Exercise price |
$ |
49.45 |
|
Stock price |
$ |
83.49 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (year) |
4.5 |
Expected volatility |
117.3 |
% |
Dividend yield |
— |
% |
Risk free rate |
3.4 |
% |
Estimated fair value per warrant |
$ |
0.75 |
|
Exercise price |
$ |
1.37 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
3.9 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.26 |
|
Exercise price |
$ |
29.90 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.2 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.39 |
|
Exercise price |
$ |
15.41 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.0 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.37 |
|
Exercise Price |
$ |
14.93 |
|
Stock Price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.3 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.41 |
|
Exercise price |
$ |
15.41 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
4.0 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.40 |
|
Exercise price |
$ |
12.91 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
|
|
Expected term (years) |
5.5 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.70 |
|
Exercise price |
$ |
2.24 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.8 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.70 |
|
Exercise price |
$ |
2.70 |
|
Stock price |
$ |
0.98 |
|
The key inputs used in the valuation were as follows:
|
|
|
|
|
|
Expected term (years) |
4.9 |
Expected volatility |
117.3 |
% |
Expected dividend rate |
— |
% |
Risk free rate |
3.6 |
% |
Estimated fair value per warrant |
$ |
0.75 |
|
Exercise price |
$ |
1.76 |
|
Stock price |
$ |
0.98 |
|
|